{"id":"https://openalex.org/W2474295058","doi":"https://doi.org/10.1158/2326-6074.tumimm14-a10","title":"Abstract A10: Soluble CD25 and C-reactive protein predict overall survival in melanoma patients receiving anti-CD40 monoclonal antibody CP-870,893 (\u03b1CD40) and anti-CTLA4 monoclonal antibody tremelimumab","display_name":"Abstract A10: Soluble CD25 and C-reactive protein predict overall survival in melanoma patients receiving anti-CD40 monoclonal antibody CP-870,893 (\u03b1CD40) and anti-CTLA4 monoclonal antibody tremelimumab","publication_year":2015,"publication_date":"2015-10-01","ids":{"openalex":"https://openalex.org/W2474295058","doi":"https://doi.org/10.1158/2326-6074.tumimm14-a10","mag":"2474295058"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6074.tumimm14-a10","doi":"https://doi.org/10.1158/2326-6074.tumimm14-a10","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm14-a10","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052264374","display_name":"Rosemarie Mick","orcid":"https://orcid.org/0009-0004-6215-0538","observed_orcids":["https://orcid.org/0009-0004-6215-0538"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rosemarie Mick","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078692994","display_name":"David Lawrence Bajor","orcid":"https://orcid.org/0000-0003-2702-5008","observed_orcids":["https://orcid.org/0000-0003-2702-5008"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Bajor","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079773324","display_name":"Lee P. Richman","orcid":"https://orcid.org/0000-0002-4601-5190","observed_orcids":["https://orcid.org/0000-0002-4601-5190"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lee Richman","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040750947","display_name":"Robert H. Vonderheide","orcid":"https://orcid.org/0000-0002-7252-954X","observed_orcids":["https://orcid.org/0000-0002-7252-954X"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Vonderheide","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"10_Supplement","first_page":"A10","last_page":"A10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-il-2-receptor","display_name":"soluble interleukin-2 receptor","score":0.8899999856948853},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":1.0},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9290000200271606},{"id":"https://openalex.org/keywords/anti-cd40-monoclonal-antibody","display_name":"anti-CD40 monoclonal antibody","score":0.847000002861023},{"id":"https://openalex.org/keywords/tremelimumab","display_name":"tremelimumab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.8009999990463257},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7170000076293945},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8450000286102295},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8429999947547913},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.7730000019073486},{"id":"https://openalex.org/keywords/serum-cytokines","display_name":"serum cytokines","score":0.6980000138282776},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5799999833106995},{"id":"https://openalex.org/keywords/tumor-stage","display_name":"tumor stage","score":0.4909999966621399},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.9399999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7412617802619934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6325264573097229},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.534659743309021},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.520548939704895},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.47666361927986145},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4521416425704956},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44760483503341675},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37446606159210205},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3640797734260559},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.15787628293037415},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.1359308660030365}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6074.tumimm14-a10","doi":"https://doi.org/10.1158/2326-6074.tumimm14-a10","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6074.tumimm14-a10","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2888050979","https://openalex.org/W2562206555","https://openalex.org/W1675447646","https://openalex.org/W2265447862","https://openalex.org/W4211025067","https://openalex.org/W2811242353","https://openalex.org/W3037564202","https://openalex.org/W2770034648","https://openalex.org/W2548397076","https://openalex.org/W2943831157"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Identifying":[2],"baseline":[3,554],"patient":[4],"biomarkers":[5,569],"that":[6],"predict":[7,592],"clinical":[8,47],"outcomes":[9],"to":[10,368,540],"cancer":[11],"immunotherapy":[12],"is":[13],"a":[14,21,131,546],"major":[15],"goal":[16],"for":[17,36,83,163,185,294,394,417,487,531,549,553],"the":[18,164,290,613],"field.":[19],"In":[20,354,470],"phase":[22],"I":[23],"dose":[24],"escalation":[25],"study":[26],"of":[27,134,257,335,377,434,573,612],"\u03b1CD40":[28],"CP-870,893":[29,602],"(0.1-0.2":[30],"mg/kg)":[31,35],"and":[32,50,53,59,74,79,113,123,144,148,155,172,189,250,270,277,286,304,334,424,446,498,524,561,589,604,619],"tremelimumab":[33],"(6-15":[34],"patients":[37,597],"(pts)":[38],"with":[39,153,193,212,233,266,273,327,338,382,396,468,504,514],"metastatic":[40,65],"melanoma,":[41],"we":[42],"determined":[43,167,183],"associations":[44],"between":[45],"pre-treatment":[46],"(stage,":[48],"LDH)":[49],"immune":[51,157,238,574],"variables":[52,158,239,349,373],"tumor":[54],"response,":[55],"progression-free":[56],"survival":[57,61,594],"(PFS)":[58],"overall":[60,593],"(OS).":[62],"Methods:":[63],"Twenty-two":[64],"melanoma":[66,596],"pts":[67,139,219,326,337,381,395],"(6":[68],"stage":[69,72,76,213,217,224,251,278,474,478,488],"4a,":[70],"6":[71,117,325],"4b":[73],"10":[75,223],"4c)":[77],"enrolled":[78],"contributed":[80],"serum":[81],"specimens":[82],"immunologic":[84],"evaluation,":[85],"which":[86],"included:":[87],"soluble":[88],"CD25":[89,588],"(sCD25),":[90],"C-reactive":[91,590],"protein":[92,591],"(CRP),":[93],"EGF,":[94],"HGF,":[95],"VEGF,":[96],"IFN\u03b1,":[97],"IFN\u03b3,":[98],"TNF\u03b1,":[99],"G-/GM-CSF,":[100],"MIP1A/1B,":[101],"MIG,":[102],"MCP1,":[103],"IL1B,":[104],"IL1RA,":[105],"IL2,":[106],"IL4,":[107],"IL5,":[108],"IL6,":[109],"IL8,":[110],"IL10,":[111],"IL12":[112],"IL13.":[114],"There":[115],"were":[116,146,159,166,197,253,312,350,431,454],"responders":[118],"(2":[119],"CR,":[120],"4":[121],"PR)":[122],"16":[124,336],"nonresponders":[125],"(3":[126],"SD,":[127],"13":[128,138],"PD).":[129],"With":[130],"median":[132,169,378,388,402,440,481,491],"follow-up":[133],"26":[135],"months":[136],"(mos),":[137],"have":[140],"died.":[141],"Median":[142],"PFS":[143,188,482,492,517],"OS":[145,389,403,520,550],"2.5":[147],"26.1":[149],"mos,":[150],"respectively.":[151,191],"Associations":[152],"continuous":[154],"binary":[156,297,305,348,358,369,408,447,463],"tested,":[160],"cut":[161,292,317],"points":[162,293,318],"latter":[165],"by":[168,439],"or":[170,179,187,235,507,519],"classification":[171],"regression":[173,181],"tree":[174],"(CART)":[175],"analysis.":[176],"Univariate":[177],"logistic":[178],"Cox":[180],"analyses":[182],"predictors":[184,256,433,530,538],"response":[186,234,515],"OS,":[190,532],"Variables":[192],"univariate":[194],"significance":[195],"<0.05":[196],"then":[198],"tested":[199],"in":[200,215,222,570,595],"multivariable":[201,471],"models":[202],"using":[203],"stepwise":[204],"regression.":[205],"Results:":[206],"Tumor":[207,617],"Response.":[208],"Response":[209],"was":[210,230,263,365,390,404,466,483,493,501,511],"associated":[211,232,352,467,513],"(50%":[214],"12":[216],"4a/b":[218,479],"vs":[220,300,308,442,450],"0%":[221],"4c":[225,489],"pts,":[226,480,490],"p=0.02).":[227],"Baseline":[228],"LDH":[229,248,274,418],"not":[231,428,462,502,536],"PFS.":[236,435],"No":[237],"predicted":[240],"response.":[241],"Overall":[242],"Survival.":[243,421],"sCD25":[244,262,284,298,328,339,359,383,397,409,425,437,464,505,523,544,560],"(p=0.01),":[245],"CRP":[246,267,287,306,332,343,386,400,429,448,459,497,508,525,562],"(p=0.005),":[247],"(p=0.006)":[249],"(p=0.01)":[252,423],"highly":[254,264,313,411,528],"significant":[255,314,362,412,432,456,529,547],"OS.":[258,295,379],"Natural":[259],"log":[260],"transformed":[261],"correlated":[265,272,503],"(r=0.56,":[268],"p=0.006)":[269],"moderately":[271],"(r=0.41,":[275],"p=0.06)":[276],"(rho=0.32,":[279],"p=0.09).":[280],"CART":[281],"analysis":[282],"identified":[283],">110":[285,398],">7":[288,333],"as":[289,566],"optimal":[291],"Accordingly,":[296],"(>110":[299],"<110,":[301,340],"HR=13.4,":[302],"p<0.001)":[303],"(>7":[307,449],"<7,":[309,451],"HR=7.2,":[310],"p=0.003)":[311],"predictors.":[315,457],"These":[316],"defined":[319,438],"very":[320],"similar":[321],"risk":[322],"groups.":[323],"Of":[324],">110,":[329],"5":[330],"had":[331,342],"14":[341],"<7.":[344],"Thus,":[345],"these":[346,558],"CART-defined":[347],"strongly":[351],"(p=0.004).":[353],"multivariate":[355],"modeling,":[356,472],"only":[357,473],"remained":[360,410,475],"statistically":[361],"since":[363],"it":[364,512],"slightly":[366],"superior":[367],"CRP,":[370],"although":[371,533],"both":[372,527],"produced":[374],"identical":[375],"estimates":[376],"For":[380,477],"<110":[384],"(or":[385,399],"<7),":[387],"27.1":[391],"mos":[392,485],"while":[393,486],">7),":[401],"4.6":[405],"mos.":[406,495],"Moreover,":[407],"(HR=11.2,":[413],"p=0.002)":[414],"after":[415,551],"adjusting":[416,552],"(p=0.06).":[419],"Progression-free":[420],"Stage":[422],"(p=0.02),":[426],"but":[427,461],"(p=0.10),":[430],"Binary":[436,458],"(>60":[441],"<60,":[443],"HR=3.1,":[444,452],"p=0.02)":[445,453],"also":[455],"(p=0.001),":[460],"(p=0.20),":[465],"stage.":[469],"significant.":[476],"4.8":[484],"2.3":[494],"sCD25,":[496],"IL6.":[499],"IL6":[500],"(p=0.99)":[506],"(p=0.83)":[509],"nor":[510],"(p=0.26),":[516],"(p=0.48)":[518],"(p=0.74).":[521],"Conclusion:":[522],"are":[526,535],"they":[534],"independent":[537],"due":[539],"their":[541],"strong":[542],"co-linearity.":[543],"remains":[545],"predictor":[548],"LDH.":[555],"To":[556],"confirm":[557],"findings,":[559],"should":[563],"be":[564],"investigated":[565],"possible":[567],"predictive":[568],"future":[571],"studies":[572],"checkpoint":[575],"inhibitors.":[576],"Citation":[577],"Format:":[578],"Rosemarie":[579],"Mick,":[580],"David":[581],"Bajor,":[582],"Lee":[583],"Richman,":[584],"Robert":[585],"Vonderheide.":[586],"Soluble":[587],"receiving":[598],"anti-CD40":[599],"monoclonal":[600,606],"antibody":[601,607],"(\u03b1CD40)":[603],"anti-CTLA4":[605],"tremelimumab.":[608],"[abstract].":[609],"In:":[610],"Proceedings":[611],"AACR":[614],"Special":[615],"Conference:":[616],"Immunology":[618],"Immunotherapy:":[620],"A":[621],"New":[622],"Chapter;":[623],"December":[624],"1-4,":[625],"2014;":[626],"Orlando,":[627],"FL.":[628],"Philadelphia":[629],"(PA):":[630],"AACR;":[631],"Cancer":[632],"Immunol":[633],"Res":[634],"2015;3(10":[635],"Suppl):Abstract":[636],"nr":[637],"A10.":[638]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-07-22T00:00:00"}